Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab

Breast cancer is the most frequently diagnosed cancer in women worldwide and the second cause of cancer-related mortality. A total of 20–30% of patients with early-stage breast cancer develop recurrence within the first 5 years following diagnosis. Trastuzumab significantly improves overall survival...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Mol Clin Oncol
Main Authors: GÜNDÜZ, SEYDA, GÖKSU, SEMA SEZGIN, ARSLAN, DENIZ, TATLI, ALI MURAT, UYSAL, MÜKREMIN, GÜNDÜZ, UMUT RIZA, SEVINÇ, MERT MAHSUNI, COŞKUN, HASAN SENOL, BOZCUK, HAKAN, MUTLU, HASAN, SAVAS, BURHAN
Format: Artigo
Sprog:Inglês
Udgivet: D.A. Spandidos 2015
Fag:
Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4534854/
https://ncbi.nlm.nih.gov/pubmed/26623060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.610
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker